Canada · Delayed Price · Currency is CAD Kits Eyecare Statistics
Total Valuation
Kits Eyecare has a market cap or net worth of CAD 478.53 million. The enterprise value is 460.68 million.
| Market Cap | 478.53M |
| Enterprise Value | 460.68M |
Important Dates
The last earnings date was Wednesday, March 4, 2026.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kits Eyecare has 33.99 million shares outstanding. The number of shares has increased by 0.57% in one year.
| Current Share Class | 33.99M |
| Shares Outstanding | 33.99M |
| Shares Change (YoY) | +0.57% |
| Shares Change (QoQ) | -1.20% |
| Owned by Insiders (%) | 26.14% |
| Owned by Institutions (%) | 14.89% |
| Float | 14.60M |
Valuation Ratios
The trailing PE ratio is 156.45 and the forward PE ratio is 55.76.
| PE Ratio | 156.45 |
| Forward PE | 55.76 |
| PS Ratio | 2.36 |
| PB Ratio | 7.68 |
| P/TBV Ratio | 21.80 |
| P/FCF Ratio | 42.24 |
| P/OCF Ratio | 41.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 43.28, with an EV/FCF ratio of 40.67.
| EV / Earnings | 148.13 |
| EV / Sales | 2.28 |
| EV / EBITDA | 43.28 |
| EV / EBIT | 55.74 |
| EV / FCF | 40.67 |
Financial Position
The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.34 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 1.49 |
| Debt / FCF | 1.40 |
| Interest Coverage | 12.28 |
Financial Efficiency
Return on equity (ROE) is 5.17% and return on invested capital (ROIC) is 10.84%.
| Return on Equity (ROE) | 5.17% |
| Return on Assets (ROA) | 4.78% |
| Return on Invested Capital (ROIC) | 10.84% |
| Return on Capital Employed (ROCE) | 12.23% |
| Weighted Average Cost of Capital (WACC) | 4.86% |
| Revenue Per Employee | 1.15M |
| Profits Per Employee | 17,670 |
| Employee Count | 176 |
| Asset Turnover | 1.87 |
| Inventory Turnover | 5.65 |
Taxes
In the past 12 months, Kits Eyecare has paid 1.94 million in taxes.
| Income Tax | 1.94M |
| Effective Tax Rate | 38.38% |
Stock Price Statistics
The stock price has increased by +28.23% in the last 52 weeks. The beta is 0.12, so Kits Eyecare's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +28.23% |
| 50-Day Moving Average | 18.52 |
| 200-Day Moving Average | 16.40 |
| Relative Strength Index (RSI) | 24.88 |
| Average Volume (20 Days) | 165,778 |
Short Selling Information
The latest short interest is 14,456, so 0.05% of the outstanding shares have been sold short.
| Short Interest | 14,456 |
| Short Previous Month | 16,245 |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kits Eyecare had revenue of CAD 202.46 million and earned 3.11 million in profits. Earnings per share was 0.09.
| Revenue | 202.46M |
| Gross Profit | 72.11M |
| Operating Income | 8.27M |
| Pretax Income | 5.05M |
| Net Income | 3.11M |
| EBITDA | 9.66M |
| EBIT | 8.27M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 33.67 million in cash and 15.82 million in debt, with a net cash position of 17.85 million or 0.53 per share.
| Cash & Cash Equivalents | 33.67M |
| Total Debt | 15.82M |
| Net Cash | 17.85M |
| Net Cash Per Share | 0.53 |
| Equity (Book Value) | 62.31M |
| Book Value Per Share | 1.93 |
| Working Capital | 15.31M |
Cash Flow
In the last 12 months, operating cash flow was 11.46 million and capital expenditures -136,000, giving a free cash flow of 11.33 million.
| Operating Cash Flow | 11.46M |
| Capital Expenditures | -136,000 |
| Depreciation & Amortization | 1.39M |
| Net Borrowing | 1.76M |
| Free Cash Flow | 11.33M |
| FCF Per Share | 0.33 |
Margins
Gross margin is 35.61%, with operating and profit margins of 4.08% and 1.54%.
| Gross Margin | 35.61% |
| Operating Margin | 4.08% |
| Pretax Margin | 2.49% |
| Profit Margin | 1.54% |
| EBITDA Margin | 4.77% |
| EBIT Margin | 4.08% |
| FCF Margin | 5.60% |
Dividends & Yields
Kits Eyecare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.57% |
| Shareholder Yield | -0.57% |
| Earnings Yield | 0.65% |
| FCF Yield | 2.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kits Eyecare has an Altman Z-Score of 6.99 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.99 |
| Piotroski F-Score | 7 |